Latest Funding News

88 Energy Limited announces a maiden internal Prospective Resource estimate of 283 million barrels of oil for its Canning Prospect at Project Leonis, Alaska, with plans to drill the Tiri-1 exploration well targeting multiple reservoirs in 2026.

Argenica Therapeutics has dosed 80% of patients in its Phase 2 stroke trial and gained FDA orphan drug designations for its second candidate, ARG-006. The company reports a cash-positive quarter with $15 million in reserves.

Kingsgate Consolidated Limited reported a 150% increase in ore mined and a 13.4% rise in gold production for the December 2024 quarter, marking its third consecutive quarter of growth. Despite some challenges with grade control and cost guidance, the company anticipates further production and efficiency gains.

ioneer Ltd’s December 2024 quarterly cash flow report reveals ongoing cash outflows from operations and investing, with nearly $4.5 million spent this quarter but a solid cash reserve providing a runway of almost five quarters.

Kingsrose Mining, in alliance with BHP, reports promising high-grade copper and polymetallic discoveries in Norway and Finland, advancing one of Europe’s largest exploration programs.

Ioneer Ltd has closed a $996 million loan from the U.S. Department of Energy to accelerate its Rhyolite Ridge Lithium-Boron Project in Nevada, following key federal permitting milestones. Construction is targeted for 2025, promising to boost domestic critical mineral supply and create hundreds of jobs.

Tryptamine Therapeutics has reported successful Phase 1b results for its IV-infused psilocin candidate TRP-8803 and promising interim data for oral psilocybin TRP-8802 in IBS treatment, while securing $6 million in new funding to accelerate clinical development.

A1 Investments & Resources Ltd reported a modest cash outflow for Q1 2024 while actively pursuing renewable energy acquisitions in Japan and Australia, contingent on regulatory approvals and shareholder consent.

OpenLearning Limited reported a 23% year-on-year increase in SaaS annual recurring revenue to $2.335 million in Q4 FY24, driven by strong growth in AI-powered products and strategic partnerships. The company also cut net operating cash outflows by over half, signaling improved operational efficiency.

NEXION Group reported a robust 30% increase in cash receipts for Q2 FY25, driven by strong sales growth and new satellite sector contracts. The company is actively expanding its footprint in Southeast Asia while funding ongoing M&A activities through convertible notes.

Tivan Limited has advanced its Speewah Fluorite Project with a $7.4 million government grant and Major Project Status, alongside a joint venture MoU with Sumitomo Corporation and promising drilling results at Sandover.

Atomo Diagnostics reports a robust Q2 FY25 with $1.2 million revenue driven by HIV self-test sales and a significant $2.44 million government grant for syphilis test development. The company advances its market footprint in Australia and New Zealand while maintaining a strong cash position.